The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Resveratrol and cancer: Challenges for clinical translation
Open accessAbstract
Significant work has been done towards identifying the health-beneficial effects of the grape antioxidant resveratrol in a variety of bioassay- and disease- models, with much research being focused on its possible application to cancer management. Despite the large number of preclinical studies dealing with different aspects of the biological effects of resveratrol, it’s translation to clinics is far from reality due to a variety of challenges. In this review, we discuss the issues and questions associated with resveratrol becoming an effective in vivo anticancer drug, from basic metabolic issues to the problems faced by incomplete understanding of the mechanism(s) of action in the body. We also explore efforts taken by researchers, both public and private, to contend with some of these issues. By examining the published data and previous clinical trials, we have attempted to identify the problems and issues that hinder the clinical translation of resveratrol for cancer management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Park, P. Y., Goldin, T., Chang, J., Markman, M., & Kundranda, M. N. (2015) · Case Reports in Oncology · doi:10.1159/000441772 · Cited by 5,273
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
Bioavailability of resveratrol
Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051
Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0022 · Cited by 824
Brown, V. A., Patel, K. R., Viskaduraki, M., Crowell, J. A., Perloff, M., Booth, T. D., Vasilinin, G., Sen, A., Schinas, A. M., Piccirilli, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2364 · Cited by 688
Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
Patel, K. R., Brown, V. A., Jones, D. J. L., Britton, R. G., Hemingway, D., Miller, A. S., West, K. P., Booth, T. D., Perloff, M., Crowell, J. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2027 · Cited by 624
Clinical trials of resveratrol
Patel, K. R., Scott, E., Brown, V. A., Gescher, A. J., Steward, W. P., & Brown, K. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05853.x · Cited by 522
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Tomé-Carneiro, J., Larrosa, M., González-Sarrías, A., Tomás-Barberán, F., García-Conesa, M., & Espín, J. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990407 · Cited by 449
Howells, L. M., Berry, D. P., Elliott, P. J., Jacobson, E. W., Hoffmann, E., Hegarty, B., Brown, K., Steward, W. P., & Gescher, A. J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0148 · Cited by 444
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Vang, O., Ahmad, N., Baile, C. A., Baur, J. A., Brown, K., Csiszar, A., Das, D. K., Delmas, D., Gottfried, C., Lin, H.-Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019881 · Cited by 437
Self-citationAlmeida, L., Vaz‐da‐Silva, M., Falcão, A., Soares, E., Costa, R., Loureiro, A. I., Fernandes‐Lopes, C., Rocha, J., Nunes, T., Wright, L., et al. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800177 · Cited by 426
In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota
Bode, L. M., Bunzel, D., Huch, M., Cho, G.-S., Ruhland, D., Bunzel, M., Bub, A., Franz, C. M., & Kulling, S. E. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.049379 · Cited by 395
Enhancing the bioavailability of resveratrol by combining it with piperine
Johnson, J. J., Nihal, M., Siddiqui, I. A., Scarlett, C. O., Bailey, H. H., Mukhtar, H., & Ahmad, N. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100117 · Cited by 339
Self-citationUnraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Jogie-Brahim, S., Feldman, D., & Oh, Y. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0028 · Cited by 323
Youn, H. S., Lee, J. Y., Fitzgerald, K. A., Young, H. A., Akira, S., & Hwang, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3339 · Cited by 268
Dose-Dependency of Resveratrol in Providing Health Benefits
Mukherjee, S., Dudley, J. I., & Das, D. K. (2010) · Dose-Response · doi:10.2203/dose-response.09-015.mukherjee · Cited by 263
Holcombe, R. F., Nguyen, A., Martinez, Stamos, M. J., Moyer, M. P., Planutis, K., Hope, & Holcombe, R. F. (2009) · Cancer Management and Research · doi:10.2147/cmar.s4544 · Cited by 248
Zhu, W., Qin, W., Zhang, K., Rottinghaus, G. E., Chen, Y.-C., Kliethermes, B., & Sauter, E. R. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.654926 · Cited by 241
Tomé-Carneiro, J., Gonzálvez, M., Larrosa, M., Yáñez-Gascón, M. J., García-Almagro, F. J., Ruiz-Ros, J. A., Tomás-Barberán, F. A., García-Conesa, M. T., & Espín, J. C. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6427-8 · Cited by 241
Popat, R., Plesner, T., Davies, F., Cook, G., Cook, M., Elliott, P., Jacobson, E., Gumbleton, T., Oakervee, H., & Cavenagh, J. (2013) · British Journal of Haematology · doi:10.1111/bjh.12154 · Cited by 226
Safety studies conducted on high-purity trans-resveratrol in experimental animals
Williams, L. D., Burdock, G. A., Edwards, J. A., Beck, M., & Bausch, J. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.06.002 · Cited by 223
Nguyen, A. V., Martinez, M. E., Stamos, M. J., Moyer, M. P., Planutis, K., Hope, C., & Holcombe, R. F. (2009) · PubMed Central · Cited by 216
Chemistry, Stability and Bioavailability of Resveratrol
Franciosoa, A., Mastromarino, P., Masci, A., d’Erme, M., & Mosca, L. (2014) · Medicinal Chemistry · doi:10.2174/15734064113096660053 · Cited by 207
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase
Pandey, P. R., Okuda, H., Watabe, M., Pai, S. K., Liu, W., Kobayashi, A., Xing, F., Fukuda, K., Hirota, S., Sugai, T., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1300-6 · Cited by 203
Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites
Hoshino, J., Park, E.-J., Kondratyuk, T. P., Marler, L., Pezzuto, J. M., van Breemen, R. B., Mo, S., Li, Y., & Cushman, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100274c · Cited by 202
Resveratrol directly targets COX‐2 to inhibit carcinogenesis
Zykova, T. A., Zhu, F., Zhai, X., Ma, W., Ermakova, S. P., Lee, K. W., Bode, A. M., & Dong, Z. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20437 · Cited by 191
Patel, K. R., Andreadi, C., Britton, R. G., Horner-Glister, E., Karmokar, A., Sale, S., Brown, V. A., Brenner, D. E., Singh, R., Steward, W. P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005870 · Cited by 190
Tumor Suppressor Role of Notch-1 Signaling in Neuroendocrine Tumors
Kunnimalaiyaan, M., & Chen, H. (2007) · The Oncologist · doi:10.1634/theoncologist.12-5-535 · Cited by 186
van Ginkel, P. R., Sareen, D., Subramanian, L., Walker, Q., Darjatmoko, S. R., Lindstrom, M. J., Kulkarni, A., Albert, D. M., & Polans, A. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0347 · Cited by 185
Resveratrol: Potential as Anticancer Agent
Aluyen, J. K., Ton, Q. N., Tran, T., Yang, A. E., Gottlieb, H. B., & Bellanger, R. A. (2012) · Journal of Dietary Supplements · doi:10.3109/19390211.2011.650842 · Cited by 183
Singh, N., Agrawal, M., & Doré, S. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400094w · Cited by 183
Pleiotropic mechanisms facilitated by resveratrol and its metabolites
Calamini, B., Ratia, K., Malkowski, M. G., Cuendet, M., Pezzuto, J. M., Santarsiero, B. D., & Mesecar, A. D. (2010) · Biochemical Journal · doi:10.1042/bj20091857 · Cited by 175
Wightman, E. L., Reay, J. L., Haskell, C. F., Williamson, G., Dew, T. P., & Kennedy, D. O. (2014) · British Journal of Nutrition · doi:10.1017/s0007114514000737 · Cited by 168
Calorie restriction and resveratrol in cardiovascular health and disease
Dolinsky, V. W., & Dyck, J. R. B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.010 · Cited by 168
Dendrimers for Enhanced Drug Solubilization
Svenson, S., & Chauhan, A. S. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.679 · Cited by 149
Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network
Nwachukwu, J. C., Srinivasan, S., Bruno, N. E., Parent, A. A., Hughes, T., Pollock, J. A., Gjyshi, O., Cavett, V. J., Nowak, J., Garcia-Ordoñez, R. D., et al. (2014) · eLife · doi:10.7554/elife.02057 · Cited by 146
Santi, C. D., Pietrabissa, A., Spisni, R., Mosca, F., & Pacifici, G. M. (2000) · Xenobiotica · doi:10.1080/004982500433282 · Cited by 141
Resveratrol‐based combinatorial strategies for cancer management
Singh, C. K., George, J., & Ahmad, N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12160 · Cited by 132
Self-citationResveratrol – pills to replace a healthy diet?
Chachay, V., Kirkpatrick, C. M. J., Hickman, I. J., Ferguson, M. L., Prins, J. B., & Martin, J. H. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03966.x · Cited by 125
Resveratrol in cancer management: where are we and where we go from here?
Ndiaye, M. A., Kumar, R., & Ahmad, N. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05851.x · Cited by 98
Self-citationZheng, J., Yang, B., Huang, T., Yu, Y., Yang, J., & Li, D. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.570895 · Cited by 96
Diet and cancer risk in Mediterranean countries: open issues
Vecchia, C. L., & Bosetti, C. (2006) · Public Health Nutrition · doi:10.1017/s1368980007668475 · Cited by 93
Resveratrol vs. calorie restriction: Data from rodents to humans
Lam, Y. Y., Peterson, C. M., & Ravussin, É. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.04.005 · Cited by 86
Dendrimers Bind Antioxidant Polyphenols and cisPlatin Drug
Abderrezak, A., Bourassa, P., Mandeville, J. S., Sedaghat‐Herati, R., & Tajmir‐Riahi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033102 · Cited by 84
Resveratrol: From Basic Studies to Bedside
Borriello, A., Bencivenga, D., Caldarelli, I., Tramontano, A., Borgia, A., Zappia, V., & Ragione, F. D. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-38007-5_10 · Cited by 82
Larrosa, M., Tomé‐Carneiro, J., Yáñez-Gascón, M. J., Alcántara, D., Selma, M. V., Beltrán, D., García‐Conesa, M., Urbán, C., Lucas, R., Tomás-Barberán, F. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1007006 · Cited by 76
Effect of resveratrol and quercetin supplementation on redox status and inflammation after exercise
McAnulty, L. S., Miller, L., Hosick, P. A., Utter, A. C., Quindry, J. C., & McAnulty, S. R. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0455 · Cited by 67
Malhotra, A., Nair, P., & Dhawan, D. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093820 · Cited by 61
Huang, W., Chen, Z., Wang, Q., Lin, M., Wu, S.-J., Yan, Q., Wu, F., Yu, X., Xie, X., Li, G., et al. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9426-y · Cited by 47
Andreadi, C., Britton, R. G., Patel, K. R., & Brown, K. (2014) · Autophagy · doi:10.4161/auto.27593 · Cited by 46
Resveratrol derivatives: a patent review (2009 – 2012)
Pezzuto, J. M., Kondratyuk, T. P., & Ogas, T. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.834888 · Cited by 39
Resveratrol–zinc combination for prostate cancer management
Singh, C. K., Pitschmann, A., & Ahmad, N. (2014) · Cell Cycle · doi:10.4161/cc.29334 · Cited by 25
Self-citationPhysical methods of resveratrol induction in grapes and grape products - a review
Tříska, J., & Houška, M. (2012) · Czech Journal of Food Sciences · doi:10.17221/115/2012-cjfs · Cited by 16
Cited by
Resveratrol and diabetes: from animal to human studies
Szkudelski, T., & Szkudelska, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.013 · Cited by 354
Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol
Chimento, A., De Amicis, F., Sirianni, R., Sinicropi, M. S., Puoci, F., Casaburi, I., Saturnino, C., & Pezzi, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061381 · Cited by 310
Metabolism and pharmacokinetics of resveratrol and pterostilbene
Wang, P., & Sang, S. (2018) · BioFactors · doi:10.1002/biof.1410 · Cited by 289
Natural products: An upcoming therapeutic approach to cancer
Dutta, S., Mahalanobish, S., Saha, S., Ghosh, S., & Sil, P. C. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.04.012 · Cited by 259
Reactive Oxygen Species a Double-Edged Sword for Mesothelioma
Benedetti, S., Nuvoli, B., Catalani, S., & Galati, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4253 · Cited by 97
Metadata
- Authors
- Singh, C. K., Ndiaye, M. A., & Ahmad, N.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 1852
- Issue
- 6
- Pages
- 1178-1185
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2082079559
- Cited by
- 265
- References
- 58
- FWCI
- 9.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.